compound 10 [Reda et al., 2026]   Click here for help

GtoPdb Ligand ID: 14748

Compound class: Synthetic organic
Comment: This compound is reported as a selective, peripherally active κ opioid receptor full agonist, with G protein-signalling bias [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 6
Topological polar surface area 85.27
Molecular weight 475.58
XLogP 0.98
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[N@@]([C@@H]1CC[C@]2([C@H]3CC4=CC=C(C5=C4[C@@]2(CC[N@]3CC6CC6)[C@@H]1O5)O)O)C(=O)/C=C/C7=CNC=C7
Isomeric SMILES C1(=C2C3=C(C=C1)C[C@@H]4[C@]5([C@@]3([C@@H]([C@@H](CC5)[N@@](C(/C=C/C6=CNC=C6)=O)C)O2)CC[N@]4CC7CC7)O)O
InChI InChI=1S/C28H33N3O4/c1-30(23(33)7-4-17-9-12-29-15-17)20-8-10-28(34)22-14-19-5-6-21(32)25-24(19)27(28,26(20)35-25)11-13-31(22)16-18-2-3-18/h4-7,9,12,15,18,20,22,26,29,32,34H,2-3,8,10-11,13-14,16H2,1H3/b7-4+/t20-,22-,26-,27+,28-/m1/s1
InChI Key QIUSOWXAJCBJBQ-BNSGUOTOSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
Although compound 10 binds to KOR, MOR and DOR, it is a weak partial agonist of MOR and DOR (in a [35S]GTPγS binding assay; 17% and 45% efficacy, respectively). In vivo, compound 10 induces antinociceptive effects in inflammatory pain models [1].
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
κ receptor Hs Agonist Full agonist 9.4 pKi - 1
⤷ pKi 9.4 (Ki 4.3x10-10 M) [1]
Description: Determined in a competitive radioligand binding assay
μ receptor Hs Agonist Partial agonist 9.3 pKi - 1
⤷ pKi 9.3 (Ki 4.6x10-10 M) [1]
Description: Determined in a competitive radioligand binding assay
δ receptor Hs Agonist Partial agonist 7.8 pKi - 1
⤷ pKi 7.8 (Ki 1.529x10-8 M) [1]
Description: Determined in a competitive radioligand binding assay
κ receptor Hs Agonist Full agonist 8.6 pEC50 - 1
⤷ pEC50 8.6 (EC50 2.32x10-9 M) 100% Emax [1]
Description: Determined in a [35S]GTPγS binding assay
μ receptor Hs Agonist Partial agonist 8.6 pEC50 - 1
⤷ pEC50 8.6 (EC50 2.32x10-9 M) 17% Emax [1]
Description: Determined in a [35S]GTPγS binding assay
δ receptor Hs Agonist Partial agonist 8.3 pEC50 - 1
⤷ pEC50 8.3 (EC50 5.43x10-9 M) 45% Emax [1]
Description: Determined in a [35S]GTPγS binding assay